查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953550

永續醫藥包裝市場－全球產業規模、佔有率、趨勢、機會及預測（依材料、製程、產品類型、最終用戶、地區及競爭格局分類，2021-2031年）

Sustainable Pharmaceutical Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material, By Process, By Product Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球永續藥品包裝市場預計將從 2025 年的 855 億美元成長到 2031 年的 1,392.6 億美元，複合年成長率為 8.47%。

該市場涵蓋以可再生、可回收和可生物分解材料製成的藥品包裝解決方案的貿易，旨在最大限度地減少對環境的影響，同時保持產品完整性。主要促進因素包括政府對減少廢棄物的嚴格監管，以及大型製藥公司所製定的雄心勃勃的環境、社會和管治 ( ESG) 目標。此外，消費者對塑膠污染日益增強的意識也促使企業轉向循環經濟模式。根據醫療塑膠回收委員會 (Medical 塑膠回收再利用 Council) 2024 年的報告顯示，醫療保健產業將佔全球溫室氣體排放的 4.4%，這凸顯了對這些環保創新技術的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 855億美元
市場規模：2031年 1392.6億美元
複合年成長率：2026-2031年 8.47%
成長最快的細分市場 可生物分解包裝
最大的市場 歐洲

儘管存在這些促進因素，但由於嚴格的監管合規標準，該行業仍面臨著許多障礙，這些障礙可能會阻礙市場的快速成長。為確保新型永續材料不會影響藥物穩定性或病人安全，需要進行複雜的檢驗流程，這通常會導致更長的研發週期和更高的營運成本。這些要求最終將減緩綠色替代品的普及，因為製造商必須應對複雜的測試，以確保環保材料的性能與傳統材料相當。

市場促進因素

政府嚴格的環境法規的實施是全球永續藥品包裝市場的主要驅動力。立法者已強制要求打破傳統的「取得、製造、丟棄」的線性模式，迫使製造商採用既能確保可回收性又不影響藥品安全性的包裝解決方案。這種監管壓力促使人們即時思考包裝設計，從而淘汰原生塑膠，並將消費後回收材料整合到無菌屏障系統中。例如，歐洲理事會於2024年12月最終確定的《關於永續包裝的新法規》規定，到2030年，市場上100%的包裝必須可回收，引導產業走向單一材料結構和可生物分解的替代方案。

同時，企業對環境、社會及治理（ESG）和永續性發展的日益重視正在推動變革，主要產業參與者正調整其營運以符合脫碳目標，從而降低聲譽風險並吸引具有環保意識的相關人員。製藥公司越來越重視生態設計原則和營運效率，不斷擴大生物基和循環材料的市場佔有率。創新是這項轉變的核心。安姆科（Amcor）於2025年10月發布的《2025年永續發展報告》重點介紹了其突破性成就：使其96%的軟包裝產品系列可回收。此外，阿普塔爾（Aptar）於2025年5月發布的《2024年企業永續發展報告》也重點介紹了該公司如何透過再利用和回收舉措，將86%的營運廢棄物從掩埋轉移出去，這體現了整個行業對資源效率的承諾。

市場挑戰

醫藥產業嚴格的合規標準對永續包裝解決方案的快速普及構成了重大障礙。與其他行業包裝變革可以相對迅速地實施不同，醫藥包裝必須將病人安全和藥物穩定性放在首位。因此，向新型可再生或可生物分解材料的過渡需要大量的驗證流程，以檢驗其與傳統材料一樣具有防潮、防光和防污染性能。這些強制性且複雜的測試程序顯著延長了研發週期，增加了營運成本，從而減緩了環保替代產品的上市速度。

這種監管瓶頸直接阻礙了市場成長，因為它為材料創新設置了很高的進入門檻。由於檢驗現有產品不確定性且耗費大量資源，製造商不願投資更環保的替代方案。產業數據也印證了永續性目標與合規義務之間的這種摩擦。根據歐洲製藥工業協會聯合會 (EFPIA) 發布的《2024 年循環經濟白皮書》，70% 的受訪產業人士認為監管要求是實施循環經濟舉措的最大挑戰之一。這項數據凸顯了新材料監管柔軟性的不足如何阻礙了產業有效擴大其永續足跡的能力。

市場趨勢

採用具備NFC和RFID追蹤功能的智慧包裝正在從根本上改變整個產業，提升價值鏈的透明度，並增強病患安全。這些技術不再局限於簡單的序列化以滿足監管要求，而是用於即時庫存管理和數位化首開檢驗，這對於高價值注射劑至關重要。這種整合使醫院能夠自動進行完整性檢查和有效期限監控，從而顯著減少藥物濫用和營運浪費。根據《包裝策略》雜誌2024年10月刊的報導“Schreiner MediPharm重點介紹RFID標籤解決方案”，該公司的RFID標籤技術已成功實現了北美醫院超過3.25億劑注射用急救和麻醉劑的數位化追蹤，充分展現了智慧連接在改善藥品物流方面的巨大潛力。

同時，採用先進的化學回收技術正成為解決產業材料品質挑戰的關鍵方案。機械回收通常無法滿足無菌屏障系統所需的嚴格純度標準，而分子級回收則能將廢棄塑膠分解成單體成分，生產出適用於封裝敏感藥物的優質原生樹脂。這種技術方法正在擴大符合嚴格監管檢驗要求的循環材料的供應。根據《包裝世界》（Pack World）2024年3月刊題為「伊士曼公司獲得高達3.75億美元的資金籌措」的報導，該公司已獲得資金用於建設一座分子回收設施，該設施每年可處理約11萬噸難分解塑膠廢棄物。這項進展將顯著增加用於製藥應用的高品質循環聚合物原料的供應。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球永續醫藥包裝市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依材質（紙、玻璃、金屬、塑膠）
    • 依生產過程（可重複使用包裝、可生物分解包裝、回收包裝）
    • 依產品類型（瓶子、蓋子與封口裝置、包裝袋/小袋、其他）
    • 依最終用戶（藥品生產、合約包裝、零售藥局、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美永續藥品包裝市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲永續藥品包裝市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區永續醫藥包裝市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲永續藥品包裝市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲永續藥品包裝市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球永續醫藥包裝市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Amcor plc
  • WestRock Company
  • Schott AG
  • Sonoco Products Company
  • Berry Global Group, Inc.
  • Mondi plc
  • Smurfit Kappa Group plc
  • Sealed Air Corporation
  • DS Smith Plc
  • KOrber AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23859

The Global Sustainable Pharmaceutical Packaging Market is projected to expand from USD 85.50 Billion in 2025 to USD 139.26 Billion by 2031, registering a CAGR of 8.47%. This market encompasses the trade of drug containment solutions manufactured from renewable, recyclable, or biodegradable materials, aiming to minimize environmental impact while preserving product integrity. Primary drivers include strict government regulations on waste reduction and ambitious environmental, social, and governance targets established by major pharmaceutical corporations. Furthermore, rising consumer awareness regarding plastic pollution is pushing companies toward circular economy models. As reported by the Healthcare Plastics Recycling Council in 2024, the healthcare industry accounted for 4.4% of global greenhouse gas emissions, underscoring the critical need for these eco-friendly advancements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 85.50 Billion
Market Size 2031USD 139.26 Billion
CAGR 2026-20318.47%
Fastest Growing SegmentBiodegradable Packaging
Largest MarketEurope

Despite these drivers, the sector encounters significant hurdles due to rigorous regulatory compliance standards that can hinder rapid market growth. The intricate validation processes necessary to ensure that new sustainable materials do not jeopardize drug stability or patient safety often lead to prolonged development schedules and higher operational expenses. These requirements ultimately delay the adoption of greener alternatives, as manufacturers must navigate complex testing to verify that eco-friendly options perform on par with traditional materials.

Market Driver

The enforcement of strict government environmental regulations serves as a primary catalyst for the Global Sustainable Pharmaceutical Packaging Market. Legislative bodies are implementing rigorous mandates to dismantle the linear "take-make-dispose" model, requiring manufacturers to adopt containment solutions that ensure recoverability without sacrificing drug safety. This regulatory pressure is forcing an immediate overhaul of packaging designs, leading to the elimination of non-recyclable plastics and the integration of post-consumer recycled content into sterile barrier systems. For instance, the European Council's finalized regulation in December 2024, titled 'Adoption of new rules for sustainable packaging', mandates that 100% of all packaging placed on the market must be recyclable by 2030, a directive driving the industry toward mono-material structures and biodegradable alternatives.

Simultaneously, the rising corporate emphasis on ESG and sustainability mandates is transformative, as major industry players align operations with decarbonization goals to mitigate reputational risks and appeal to environmentally conscious stakeholders. Pharmaceutical entities are increasingly prioritizing eco-design principles and operational efficiency, boosting the market share of bio-based and circular materials. Technological innovation is central to this shift; Amcor's 'Fiscal 2025 Sustainability Report' from October 2025 notes that the company achieved a milestone where 96% of its flexible packaging portfolio is now recycle-ready. Furthermore, Aptar's '2024 Corporate Sustainability Report' from May 2025 highlights that the firm avoided landfill disposal for 86% of its operational waste through reuse and recovery initiatives, reflecting a sector-wide commitment to resource efficiency.

Market Challenge

The rigorous regulatory compliance standards governing the pharmaceutical industry present a formidable barrier to the rapid adoption of sustainable packaging solutions. Unlike other sectors where packaging changes can be implemented relatively quickly, pharmaceutical packaging must primarily ensure patient safety and drug stability. Consequently, any transition to novel renewable or biodegradable materials requires extensive validation processes to verify that they offer the same level of protection against moisture, light, and contamination as traditional materials. These mandatory and complex testing procedures significantly extend development timelines and inflate operational costs, thereby reducing the speed at which eco-friendly alternatives can be brought to market.

This regulatory bottleneck directly hampers market growth by creating a high threshold for material innovation. Manufacturers face hesitation in investing in greener alternatives due to the uncertainty and resource intensity associated with re-validating existing products. This friction between sustainability goals and compliance obligations is substantiated by industry data. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in its 2024 White Paper on the Circular Economy, 70% of industry respondents identified regulatory requirements as one of the greatest challenges when implementing circular economy initiatives. This statistic underscores how the lack of regulatory flexibility for new materials stifles the sector's ability to expand its sustainable footprint effectively.

Market Trends

The implementation of smart packaging with NFC and RFID tracking is fundamentally reshaping the sector by enhancing supply chain visibility and patient safety. Beyond simple serialization for regulatory compliance, these technologies are now being leveraged for real-time inventory management and digital first-opening verification, which are critical for high-value injectable drugs. This integration allows hospitals to automate integrity checks and expiration monitoring, significantly reducing medication errors and operational waste. According to Packaging Strategies, October 2024, in the article 'Schreiner MediPharm to Highlight RFID Label Solutions', the company's RFID labeling technology has successfully enabled the digital tracking of over 325 million units of injectable emergency and anesthetic drugs in North American hospitals, demonstrating the scale at which intelligent connectivity is improving pharmaceutical logistics.

Simultaneously, the incorporation of advanced chemical recycling technologies is emerging as a vital solution to the industry's material quality challenges. While mechanical recycling often fails to meet the stringent purity standards required for sterile barrier systems, molecular recycling depolymerizes waste plastics into their monomer building blocks, allowing for the creation of virgin-quality resins suitable for sensitive drug containment. This technological pathway is unlocking the availability of circular materials that satisfy rigorous regulatory validation requirements. According to Pack World, March 2024, in the article 'Eastman Awarded Up To $375 Million', the company secured funding to construct a molecular recycling facility with the capacity to process approximately 110,000 metric tons of hard-to-recycle plastic waste annually, a development that substantially increases the feedstock of high-grade circular polymers available for pharmaceutical applications.

Key Market Players

  • Amcor plc
  • WestRock Company
  • Schott AG
  • Sonoco Products Company
  • Berry Global Group, Inc.
  • Mondi plc
  • Smurfit Kappa Group plc
  • Sealed Air Corporation
  • DS Smith Plc
  • KOrber AG

Report Scope

In this report, the Global Sustainable Pharmaceutical Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sustainable Pharmaceutical Packaging Market, By Material

  • Paper
  • Glass
  • Metal
  • Plastic

Sustainable Pharmaceutical Packaging Market, By Process

  • Reusable Packaging
  • Biodegradable Packaging
  • Recycled Packaging

Sustainable Pharmaceutical Packaging Market, By Product Type

  • Bottles
  • Caps & Closures
  • Pouches & Sachets
  • Others

Sustainable Pharmaceutical Packaging Market, By End User

  • Pharma Manufacturing
  • Contract Packaging
  • Retail Pharmacy
  • Others

Sustainable Pharmaceutical Packaging Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sustainable Pharmaceutical Packaging Market.

Available Customizations:

Global Sustainable Pharmaceutical Packaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sustainable Pharmaceutical Packaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material (Paper, Glass, Metal, Plastic)
    • 5.2.2. By Process (Reusable Packaging, Biodegradable Packaging, Recycled Packaging)
    • 5.2.3. By Product Type (Bottles, Caps & Closures, Pouches & Sachets, Others)
    • 5.2.4. By End User (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Sustainable Pharmaceutical Packaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By Process
    • 6.2.3. By Product Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Sustainable Pharmaceutical Packaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material
        • 6.3.1.2.2. By Process
        • 6.3.1.2.3. By Product Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Sustainable Pharmaceutical Packaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material
        • 6.3.2.2.2. By Process
        • 6.3.2.2.3. By Product Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Sustainable Pharmaceutical Packaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material
        • 6.3.3.2.2. By Process
        • 6.3.3.2.3. By Product Type
        • 6.3.3.2.4. By End User

7. Europe Sustainable Pharmaceutical Packaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By Process
    • 7.2.3. By Product Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Sustainable Pharmaceutical Packaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material
        • 7.3.1.2.2. By Process
        • 7.3.1.2.3. By Product Type
        • 7.3.1.2.4. By End User
    • 7.3.2. France Sustainable Pharmaceutical Packaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material
        • 7.3.2.2.2. By Process
        • 7.3.2.2.3. By Product Type
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Sustainable Pharmaceutical Packaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material
        • 7.3.3.2.2. By Process
        • 7.3.3.2.3. By Product Type
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Sustainable Pharmaceutical Packaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Material
        • 7.3.4.2.2. By Process
        • 7.3.4.2.3. By Product Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Sustainable Pharmaceutical Packaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Material
        • 7.3.5.2.2. By Process
        • 7.3.5.2.3. By Product Type
        • 7.3.5.2.4. By End User

8. Asia Pacific Sustainable Pharmaceutical Packaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By Process
    • 8.2.3. By Product Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Sustainable Pharmaceutical Packaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material
        • 8.3.1.2.2. By Process
        • 8.3.1.2.3. By Product Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Sustainable Pharmaceutical Packaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material
        • 8.3.2.2.2. By Process
        • 8.3.2.2.3. By Product Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Sustainable Pharmaceutical Packaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material
        • 8.3.3.2.2. By Process
        • 8.3.3.2.3. By Product Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Sustainable Pharmaceutical Packaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Material
        • 8.3.4.2.2. By Process
        • 8.3.4.2.3. By Product Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Sustainable Pharmaceutical Packaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Material
        • 8.3.5.2.2. By Process
        • 8.3.5.2.3. By Product Type
        • 8.3.5.2.4. By End User

9. Middle East & Africa Sustainable Pharmaceutical Packaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By Process
    • 9.2.3. By Product Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Sustainable Pharmaceutical Packaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material
        • 9.3.1.2.2. By Process
        • 9.3.1.2.3. By Product Type
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Sustainable Pharmaceutical Packaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material
        • 9.3.2.2.2. By Process
        • 9.3.2.2.3. By Product Type
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Sustainable Pharmaceutical Packaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material
        • 9.3.3.2.2. By Process
        • 9.3.3.2.3. By Product Type
        • 9.3.3.2.4. By End User

10. South America Sustainable Pharmaceutical Packaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By Process
    • 10.2.3. By Product Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Sustainable Pharmaceutical Packaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Material
        • 10.3.1.2.2. By Process
        • 10.3.1.2.3. By Product Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Sustainable Pharmaceutical Packaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Material
        • 10.3.2.2.2. By Process
        • 10.3.2.2.3. By Product Type
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Sustainable Pharmaceutical Packaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Material
        • 10.3.3.2.2. By Process
        • 10.3.3.2.3. By Product Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Sustainable Pharmaceutical Packaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Amcor plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. WestRock Company
  • 15.3. Schott AG
  • 15.4. Sonoco Products Company
  • 15.5. Berry Global Group, Inc.
  • 15.6. Mondi plc
  • 15.7. Smurfit Kappa Group plc
  • 15.8. Sealed Air Corporation
  • 15.9. DS Smith Plc
  • 15.10. KOrber AG

16. Strategic Recommendations

17. About Us & Disclaimer